Clinical Outcomes after Proton Partial-Breast Radiotherapy for Early-Stage, Hormone Receptor-Positive Breast Cancer: 3-Year Outcomes of a Phase II Trial

被引：3
作者：
Choi, I. J. [1 ]
Prabhu, K., Jr. [2 ]
Hartsell, W. F. [3 ]
Sinesi, C. C. [4 ]
Vargas, C. E. [5 ,6 ]
Benda, R. K. [7 ]
Cahlon, O. [8 ]
Chang, A. L. [9 ]
机构：
[1] New York Proton Ctr, New York, NY USA
[2] Procure Proton Therapy Ctr, Oklahoma City, OK USA
[3] Northwestern Med Chicago Proton Ctr, Warrenville, IL USA
[4] Hampton Univ, Proton Therapy Inst, Hampton, VA 23668 USA
[5] Mayo Clin, Scottsdale, AZ USA
[6] Mayo Clin Arizona, Dept Radiat Oncol, Phoenix, AZ USA
[7] Boca Raton Reg Hosp, Boca Raton, FL USA
[8] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[9] Calif Protons Canc Therapy Ctr, San Diego, CA USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2019年 / 105卷 / 01期
关键词：
D O I：
10.1016/j.ijrobp.2019.06.659
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2042
引用
收藏
页码：E19 / E19
页数：1
相关论文
共 50 条
  • [41] Updates on Adjuvant Therapy for Early Stage Hormone Receptor-Positive Breast Cancer
    Cavalcante, Ludimila L.
    Santa-Maria, Cesar A.
    AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2016, 12 (12) : 18 - 23
  • [42] A phase II trial of cabozantinib in hormone receptor-positive breast cancer with bone metastases.
    Xu, Jing
    Higgins, Michaela Jane
    Tolaney, Sara M.
    Come, Steven E.
    Smith, Matthew Raymond
    Fornier, Monica N.
    Mahmood, Umar
    Yeap, Beow Y.
    Chabner, Bruce Allan
    Isakoff, Steven J.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [43] Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET Trial
    Chan, Arlene
    Moy, Beverly
    Mansi, Janine
    Ejlertsen, Bent
    Holmes, Frankie Ann
    Chia, Stephen
    Iwata, Hiroji
    Gnant, Michael
    Loibl, Sibylle
    Barrios, Carlos H.
    Somali, Isil
    Smichkoska, Snezhana
    Martinez, Noelia
    Alonso, Mirta Garcia
    Link, John S.
    Mayer, Ingrid A.
    Cold, Soren
    Murillo, Serafin Morales
    Senecal, Francis
    Inoue, Kenichi
    Ruiz-Borrego, Manuel
    Hui, Rina
    Denduluri, Neelima
    Patt, Debra
    Rugo, Hope S.
    Johnston, Stephen R. D.
    Bryce, Richard
    Zhang, Bo
    Xu, Feng
    Wong, Alvin
    Martin, Miguel
    CLINICAL BREAST CANCER, 2021, 21 (01) : 80 - +
  • [44] Partial breast irradiation for early breast cancer:: 3-year results of the German-Austrian phase II-trial
    Ott, OJ
    Pötter, R
    Hildebrandt, G
    Hammer, J
    Lotter, M
    Beckmann, MW
    Sauer, R
    Strnad, V
    ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN, 2005, 177 (07): : 962 - 967
  • [45] Omitting Adjuvant Radiotherapy for Hormone Receptor-Positive Early-Stage Breast Cancer in Old Age: A Propensity Score Matched SEER Analysis
    Kim, Yi-Jun
    Shin, Kyung Hwan
    Kim, Kyubo
    CANCER RESEARCH AND TREATMENT, 2019, 51 (01): : 326 - 336
  • [46] Comparative effectiveness of radiotherapy for early-stage hormone receptor-positive breast cancer in elderly women using real-world data
    Ali, Askal A.
    Tawk, Rima
    Xiao, Hong
    Campbell, Ellen
    Semykina, Anastasia
    Montero, Alberto J.
    Mogos, Muluberhan
    Diaby, Vakaramoko
    CANCER MEDICINE, 2019, 8 (01): : 117 - 127
  • [47] Characterization of Clinical Symptoms by Race Among Women With Early-Stage, Hormone Receptor-Positive Breast Cancer Before Starting Chemotherapy
    Hu, Xin
    Chehal, Puneet K.
    Kaplan, Cameron
    Krukowski, Rebecca A.
    Lan, Roy H.
    Stepanski, Edward
    Schwartzberg, Lee
    Vidal, Gregory
    Graetz, Ilana
    JAMA NETWORK OPEN, 2021, 4 (06) : E2112076
  • [48] Effect of level of hormone-receptor expression on treatment outcomes of "triple-positive" early-stage breast cancer
    Abdel-Razeq, Hikmat
    Edaily, Sarah
    Iweir, Sereen
    Salam, Mourad
    Saleh, Yacob
    Sughayer, Maher
    Salama, Osama
    Mustafa, Rawan
    Almasri, Yosra
    Bater, Rayan
    Taqash, Ayat
    CANCER RESEARCH, 2021, 81 (04)
  • [49] Effect of level of hormone-receptor expression on treatment outcomes of “triple-positive” early-stage breast cancer
    Hikmat Abdel-Razeq
    Sara Edaily
    Sereen Iweir
    Mourad Salam
    Yacob Saleh
    Maher Sughayer
    Osama Salama
    Rawan Mustafa
    Yosra Al-Masri
    Rayan Bater
    Ayat Taqash
    Breast Cancer Research and Treatment, 2021, 185 : 459 - 467
  • [50] Analysis of Prosigna in hormone receptor-positive early-stage breast cancer cohort after 8 years of experience at a single institution
    Morchon Araujo, D.
    Olivares Hernandez, A.
    Figuero Perez, L.
    Claros Ampuero, J.
    Garcia Munoz, M.
    Roldan-Ruiz, J.
    Garijo Martinez, M. D. C.
    Teran Brage, E.
    Lopez Gutierrez, A.
    Sancho de Salas, M.
    Gomez Munoz, A.
    Seijas Tamayo, R.
    Lozano Mejorada, R.
    Marcos Sanchez, R. A.
    Fonseca Sanchez, E.
    Rodriguez Sanchez, C. A.
    ANNALS OF ONCOLOGY, 2023, 34 : S296 - S296
12345